Scientific Advice For Biosimilar Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On September 30, 2021, the European Medicines Agency (EMA) released a report entitled “Tailored Scientific Advice for Biosimilar Development,” describing results from its pilot program.

Scientific advice working partyScientific advice for biosimilar developmentBiologics working partyEuropean medicines agencyBiosimilar medicinal products working partyCommittee for medicinal products human useScientific adviceBiosimilar developmentEuropean economic areaMedicinal productsHuman use